Dube Michael P 4
4 · Intellia Therapeutics, Inc. · Filed Mar 3, 2026
Insider Transaction Report
Form 4
Dube Michael P
VP, Chief Accounting Officer
Transactions
- Award
Common Stock
[F1]2026-03-01+17,250→ 69,527 total
Footnotes (1)
- [F1]Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit.
Signature
James Basta, attorney-in-fact|2026-03-03